Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 671.10K | 674.60K | 445.30K | 453.90K | 662.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 671.10K | 674.60K | 445.30K | 453.90K | 662.80K |
| Cost of Revenue | 222.70K | 223.80K | 198.70K | 202.60K | 207.20K |
| Gross Profit | 448.50K | 450.80K | 246.60K | 251.30K | 455.60K |
| SG&A Expenses | 541.80K | 544.60K | 432.90K | 441.20K | 669.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -82.00K | -83.60K | -25.00K |
| Total Operating Expenses | 949.90K | 954.80K | 612.40K | 624.20K | 923.80K |
| Operating Income | -278.80K | -280.20K | -167.10K | -170.30K | -261.00K |
| Income Before Tax | -344.40K | -346.20K | -463.30K | -472.30K | -335.50K |
| Income Tax Expenses | -- | -- | -600.00 | -600.00 | 600.00 |
| Earnings from Continuing Operations | -344.40K | -346.20K | -462.70K | -471.60K | -336.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -344.40K | -346.20K | -462.70K | -471.60K | -336.10K |
| EBIT | -278.80K | -280.20K | -167.10K | -170.30K | -261.00K |
| EBITDA | -254.20K | -255.50K | -152.80K | -155.70K | -237.20K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.89B | 1.89B | 1.66B | 1.66B | 703.23M |
| Average Diluted Shares Outstanding | 1.89B | 1.89B | 1.66B | 1.66B | 703.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
